"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh ...

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

Moreover, Alcon’s market share gains in the contact lens segment and upcoming product launches like PanOptix Pro and Unity are promising. Saxon also points to the forthcoming Capital Markets Day as a ...

"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh with ...

Endicott, Alcon's Chief Executive Officer, in a statement. Segment Results Surgical growth reflected strength in international markets Surgical net sales, which include implantable lenses ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...